• Company News: Merck (MRK) quarterly results miss analysts’ estimates

Market news

4 February 2021

Company News: Merck (MRK) quarterly results miss analysts’ estimates

Merck (MRK) reported Q4 FY 2020 earnings of $1.32 per share (versus $1.16 per share in Q4 FY 2019), missing analysts’ consensus estimate of $1.39 per share.

The company’s quarterly revenues amounted to $12.514 bln (+5.4% y/y), missing analysts’ consensus estimate of $12.650 bln.

The company also issued upside guidance for FY 2021, projecting EPS of $6-48-6.68 versus analysts’ consensus estimate of $6.19 and revenues of $51.8-53.8 bln versus analysts’ consensus estimate of $51.58 bln.

MRK rose to $77.40 (+0.10%) in pre-market trading.

Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer
Open Demo Account & Personal Page
I understand and accept the Privacy Policy and agree to my name and contact details being used by TeleTrade to contact me about this.